[go: up one dir, main page]

AU3920293A - Novel metal binding agents, and methods and compositions for their use to treat metal toxicity - Google Patents

Novel metal binding agents, and methods and compositions for their use to treat metal toxicity

Info

Publication number
AU3920293A
AU3920293A AU39202/93A AU3920293A AU3920293A AU 3920293 A AU3920293 A AU 3920293A AU 39202/93 A AU39202/93 A AU 39202/93A AU 3920293 A AU3920293 A AU 3920293A AU 3920293 A AU3920293 A AU 3920293A
Authority
AU
Australia
Prior art keywords
compositions
methods
binding agents
treat
toxicity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU39202/93A
Inventor
Patrick L. Iversen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Nebraska System
Original Assignee
University of Nebraska Lincoln
University of Nebraska System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Nebraska Lincoln, University of Nebraska System filed Critical University of Nebraska Lincoln
Publication of AU3920293A publication Critical patent/AU3920293A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/7125—Nucleic acids or oligonucleotides having modified internucleoside linkage, i.e. other than 3'-5' phosphodiesters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/315—Phosphorothioates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU39202/93A 1993-03-16 1993-03-16 Novel metal binding agents, and methods and compositions for their use to treat metal toxicity Abandoned AU3920293A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1993/002363 WO1994021243A1 (en) 1993-03-16 1993-03-16 Novel metal binding agents, and methods and compositions for their use to treat metal toxicity

Publications (1)

Publication Number Publication Date
AU3920293A true AU3920293A (en) 1994-10-11

Family

ID=22236405

Family Applications (1)

Application Number Title Priority Date Filing Date
AU39202/93A Abandoned AU3920293A (en) 1993-03-16 1993-03-16 Novel metal binding agents, and methods and compositions for their use to treat metal toxicity

Country Status (3)

Country Link
EP (1) EP0689433A4 (en)
AU (1) AU3920293A (en)
WO (1) WO1994021243A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6140305A (en) 1996-04-04 2000-10-31 Bio-Rad Laboratories, Inc. Hereditary hemochromatosis gene products
US7026116B1 (en) 1996-04-04 2006-04-11 Bio-Rad Laboratories, Inc. Polymorphisms in the region of the human hemochromatosis gene
US6849399B1 (en) 1996-05-23 2005-02-01 Bio-Rad Laboratories, Inc. Methods and compositions for diagnosis and treatment of iron misregulation diseases
CA2293808C (en) 1997-06-13 2006-10-17 Progenitor, Inc. Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases
CN110105446B (en) * 2019-04-11 2022-02-18 中国科学院遗传与发育生物学研究所农业资源研究中心 Metallothionein gene MT27, metallothionein obtained by encoding metallothionein gene MT27, expression and application of metallothionein

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3163784A (en) * 1983-08-08 1985-02-14 Smithkline Beckman Corporation Yeast copper - metallothionein gene
IL90359A0 (en) * 1988-05-26 1989-12-15 University Patents Inc Nucleoside and polynucleotide thiophosphoramidite and phosphorodithioate compounds and their production
US5618796A (en) * 1991-09-12 1997-04-08 The Board Of Regents Of The University Of Nebraska Metal binding oligonucleotide and methods and compositions for their use to treat metal toxicity

Also Published As

Publication number Publication date
EP0689433A4 (en) 1999-10-20
EP0689433A1 (en) 1996-01-03
WO1994021243A1 (en) 1994-09-29

Similar Documents

Publication Publication Date Title
AU3686495A (en) Benzothiophene compounds, compositions, and methods
AU7323294A (en) Perfluoroelastomeric compositions and methods
AU7480094A (en) Thermite compositions for use as gas generants
AU7337694A (en) Thermite compositions for use as gas generants
AU2616695A (en) Synergistic composition
AU1296099A (en) Methods and compositions for treating dermatoses
AU6082296A (en) Low leaching compositions for wood
HU9503250D0 (en) Pyridazinones and their use as fungicides and compositions containing them
EP0611302A4 (en) Methods and compositions for treating allergic reactions.
EP0637450A3 (en) Composition for revitalizing scar tissue.
AU2113295A (en) Novel compositions and methods for water treatment
SG47858A1 (en) Composition for treating copper or copper alloys
HU9503609D0 (en) Arylacetamides, process for their preparation, compositions containing them and their use as fungicides
AU5254696A (en) Reduced toxicity compositions and methods for treating hiv infections
HUP9900071A3 (en) Tribenzimidazoles useful as topoisomerase i inhibitors, pharmaceutical compositions containing them and their use
ZA966063B (en) Synergistic herbicidal composition and method of use thereof.
AU4057197A (en) Composition to aid in the forming of metal
EG20569A (en) Novel (1-heteroazolyl -1- heterocyclyl ) alkane derivatives and their use as neuroprotective agents
AU3234995A (en) Use of il-6 to treat toxic shock
AU7437094A (en) Disinfectant-detergent composition
AU1842195A (en) Compositions and methods for inhibiting microbial binding to surfaces
AU8851298A (en) L-threonate ferrous, as well as pharmaceutical composition and use for improvingand treating human anemia thereof
AU3920293A (en) Novel metal binding agents, and methods and compositions for their use to treat metal toxicity
AU1841195A (en) 1-beta -methyl-carbapenem, compositions containing same and methods of use
AU672124B2 (en) Composition